IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures

Abroad (travel likely)Recruiting

Conditions

Cancer Metastatic · Trauma · Pathologic Fracture

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Kevin A Raskin, MD) · kraskin@mgh.harvard.edu · 617-724-3700
Contact: Study coordinator (Shreya Halur, BS) · shalur@mgh.harvard.edu · 617-726-4932
Contact: Principal Investigator (Kevin A Raskin, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer Metastatic

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Cancer Patients in China.

Breast Cancer Metastatic

Abroad (travel likely)Recruiting

Hangzhou, China

Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

Breast Cancer Metastatic

Abroad (travel likely)RecruitingPHASE1

San Antonio, United States

Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer

Breast Cancer Metastatic

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea